Startups and Transfers


INFORMATION TECHNOLOGIES – Pre-commercialization



Digital health platform specifically designed for cancer treatment

CaptoMD is a cloud-based platform that provides a variety of tools designed to help clinicians and patients take better-informed clinical decisions. By gathering complete clinical data, CaptoMD enables easy access to a patient’s complete medical history and to key clinical indicators and trends. More specifically, using artificial intelligence, this system improves the efficiency of the cancer care pathway and increases the standardization of pre, per and post-consultation assessment. CaptoMD is currently solely dedicated to prostate cancer, it is nevertheless designed to adapt to any other tumor sites, including bladder, lungs, and colorectal cancer.

Sommaire Capto MD 002


Vincent Fradet, M.D., Ph.D., FRCSC
Co-Founder & CEO